Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
Authors
Keywords
Sarcoma, Solitary fibrous tumour, Treatment, Metastasis, Chemotherapy, Anthracycline, Doxorubicin, Ifosfamide, Dacarbazine, Trabectedin, Eribulin, Xenograft, Mice model
Journal
EUROPEAN JOURNAL OF CANCER
Volume 76, Issue -, Pages 84-92
Publisher
Elsevier BV
Online
2017-03-09
DOI
10.1016/j.ejca.2017.02.002

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.